The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung Cancer Article

Nagasaka, Misako, Singh, Vijendra, Baca, Yasmine et al. (2022). The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung Cancer . Clinical Lung Cancer, 23(1), 52-59. 10.1016/j.cllc.2021.08.012

Open Access International Collaboration

cited authors

  • Nagasaka, Misako; Singh, Vijendra; Baca, Yasmine; Sukari, Ammar; Kim, Chul; Mamdani, Hirva; Spira, Alexander; Uprety, Dipesh; Bepler, Gerold; Kim, Edward S; Raez, Luis E; Pai, Sachin Gopalkrishna; Ikpeazu, Chukwuemeka; Oberley, Matthew; Feldman, Rebecca; Xiu, Joanne; Korn, W Michael; Wozniak, Antoinette J; Borghaei, Hossein; Liu, Stephen

sustainable development goals

authors

publication date

  • January 1, 2022

published in

keywords

  • COMBINATION
  • COPY NUMBER
  • ERBB2 mutation
  • Epidermal growth factor receptor mutation
  • GENE AMPLIFICATION
  • HER-2/NEU
  • HER2 amplification
  • HER2 mutation
  • HER2-ACTIVATING MUTATIONS
  • IMMUNOHISTOCHEMISTRY
  • IN-SITU HYBRIDIZATION
  • Life Sciences & Biomedicine
  • Next generation sequencing
  • Oncology
  • PHASE-II
  • PROTEIN EXPRESSION
  • Science & Technology
  • TRASTUZUMAB

Digital Object Identifier (DOI)

start page

  • 52

end page

  • 59

volume

  • 23

issue

  • 1